FindTrial
Sign In

The Additional Effect of Baduanjin on Improving the Quality of Life in Menopausal Women

The Additional Effect of Baduanjin on Improving the Quality of Life in Menopausal Women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001718
Enrollment
Unknown
Registered
2026-07-09
Start date
2026-07-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

menopause

Interventions

control group:health education
Baduanjin group:health education+Baduanjin

Sponsors

Women's Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 55 Years

Inclusion criteria

Inclusion criteria: Women aged =45 years with prominent menopausal symptoms and impaired quality of life (Kupperman Menopausal Index score > 6 points).

Exclusion criteria

Exclusion criteria: Regular use of hormone replacement therapy or high-dose phytoestrogen supplements within the past month; presence of severe physical illness, severe osteoarthritis or limited motor function that prevents safe and independent completion of Baduanjin exercises; diagnosis of severe mental disorders (e.g., major depressive disorder, schizophrenia).

Design outcomes

Primary

MeasureTime frame
Menopause-Specific Quality of Life Questionnaire;—

Secondary

MeasureTime frame
Kupperman Menopausal Index;Patient Health Questionnaire-4;—

Countries

Australia

Contacts

Public ContactFan Qu

Women's Hospital, School of Medicine, Zhejiang University

syqufan@zju.edu.cn13429119143

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026